The ever-developing nature of Pharma means that the industry is constantly seeking ways to revolutionise drug development and improve health outcomes.

The healthcare domain continues to grow more patient-centred, making real-world patient outcomes crucial to sustain Pharma’s strive to make an impact in healthcare.

Traditionally, Pharma has been heavily centred around the collection of clinical data. However, there is a growing emphasis on understanding patient experiences beyond clinical settings. Real-world patient outcomes (RWPO) provide insights into a person’s health, well-being, and daily life. This information includes details about symptoms, quality of life, and how individuals manage their daily activities. RWPO is gathered, with patient consent, using familiar tools like smartphone health apps and wearable devices, with all data kept anonymous to protect privacy. The goal of collecting RWPO is to enhance patient outcomes, guide healthcare decisions from a patient-focused perspective, and support the development of better treatments.

A key question arises: What exactly are the benefits of RWPO beyond the clinic?
Data collected in real-world settings offer greater validity because they account for the unpredictability of everyday life, unlike data from controlled clinical environments. This leads to a more nuanced understanding of chronic and rare conditions, ultimately enhancing the development of drugs, therapies, and services tailored to patient needs. By capturing a comprehensive view of patient experiences, RWPO beyond the clinic plays a crucial role in driving new advancements in Pharma and healthcare.

Sanius health recognises the compatibility of healthcare and data that is collected beyond the traditional means. This is evident through our implementation of wearable technology and a smartphone application, which enable patients to identify and predict patterns and trends, record and share key data with clinicians, gain insights into triggers, and highlight emerging crises outside of the clinical setting. Through offering personalised health monitoring and support, Sanius Health empowers patients and enables researchers to collect comprehensive, real-world patient datasets for drug development. Moreover, our data-driven collection of patient progress and outcomes ensures that we help fill the gaps left by traditional clinical trials, offering valuable information for improving treatment and patient care strategies.

Our collection of RWPO beyond the clinic provides the grounds to revolutionise healthcare. We provide a wide breadth and depth of data from medical records, patient-reported outcomes, remote monitoring data, genomics data, pathology, diagnostics and more – all of which aid our contribution to and support of clinical research in Pharma.

Ultimately, the future of Pharma lies heavily in the adoption of data collected outside the traditional sphere of a clinical setting. This is not to say that data collected within clinical trials are no longer useful, but rather should be reviewed in combination with data collected during patients’ everyday lives. By leveraging the strengths of RWPO beyond the clinic, we can journey towards wide-scale developments in Pharma which ensure better patient outcomes and progress in medicine for those with rare and chronic conditions.